Molecular structure of the NQTrp inhibitor with the Alzheimer Aβ1-28 monomer

European Journal of Medicinal Chemistry

Volumn 91, Issue , 2015, Pages 43-50

  Tarus, Bogdan ^a   Nguyen, Phuong H ^a   Berthoumieu, Olivia ^b,c   Faller, Peter ^b,c   Doig, Andrew J ^d   Derreumaux, Philippe ^a,e  

^a France   (France)

^b LCC LABORATOIRE DE CHIMIE DE COORDINATION   (France)

^c UNIVERSITÉ PAUL SABATIER   (France)

^d UNIVERSITY OF MANCHESTER   (United Kingdom)

^e INSTITUT UNIVERSITAIRE DE FRANCE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

AMYLOID BETA PROTEIN; AMYLOID BETA PROTEIN [1-28]; UNCLASSIFIED DRUG; 1,4-NAPHTHOQUINON-2-YLTRYPTOPHAN; AMYLOID BETA-PROTEIN (1-28); NAPHTHOQUINONE; PEPTIDE FRAGMENT; PROTEIN BINDING; TRYPTOPHAN;

ALPHA HELIX; ALZHEIMER DISEASE; ARTICLE; CHEMICAL STRUCTURE; CIRCULAR DICHROISM; ELECTROSPRAY; KINETICS; MOLECULAR DYNAMICS; NUCLEAR MAGNETIC RESONANCE; PROTEIN AGGREGATION; PROTEIN BINDING; PROTEIN INTERACTION; PROTEIN SECONDARY STRUCTURE; ANALOGS AND DERIVATIVES; ANTAGONISTS AND INHIBITORS; CHEMISTRY; HUMAN; PROTEIN FOLDING; PROTEIN MULTIMERIZATION; THERMODYNAMICS;

AMYLOID BETA-PEPTIDES; HUMANS; KINETICS; MOLECULAR DYNAMICS SIMULATION; NAPHTHOQUINONES; PEPTIDE FRAGMENTS; PROTEIN BINDING; PROTEIN FOLDING; PROTEIN MULTIMERIZATION; PROTEIN STRUCTURE, SECONDARY; THERMODYNAMICS; TRYPTOPHAN;

EID: 84921504995     PISSN: 02235234     EISSN: 17683254     Source Type: Journal    
DOI: 10.1016/j.ejmech.2014.07.002     Document Type: Article

References (47)

1. D.J. Selkoe Folding proteins in fatal ways Nature 426 2003 900 904
2. G.M. Shankar S. Li T.H. Mehta A. Garcia-Munoz N.E. Shepardson I. Smith F.M. Brett M.A. Farrell M.J. Rowan C.A. Lemere C.M. Regan D.M. Walsh B.L. Sabatini D.J. Selkoe Amyloid-beta protein dimers isolated directly from Alzheimer's brains impair synaptic plasticity and memory Nat. Med. 14 2008 837 842
3. W.F. Xue A.L. Hellewell W.S. Gosal S.W. Homans E.W. Hewitt S.E. Radford Fibril fragmentation enhances amyloid cytotoxicity J. Biol. Chem. 284 2009 34272 34282
4. M.G. Sharoar M. Shahnawaz M.I. Islam V.S. Ramasamy S.Y. Shin I.S. Park The inhibitory effects of Escherichia coli maltose binding protein on β-amyloid aggregation and cytotoxicity Arch. Biochem. Biophys. 538 2013 41 48
5. T. Takahashi H. Mihara Peptide and protein mimetics inhibiting amyloid beta-peptide aggregation Acc. Chem. Res. 41 2008 1309 1318
6. W. Hoyer C. Grönwall A. Jonsson S. Ståhl T. Härd Stabilization of a beta-hairpin in monomeric Alzheimer's amyloid-beta peptide inhibits amyloid formation Proc. Natl. Acad. Sci. U. S. A. 105 2008 5099 5104
7. R.D. Bell M.D. Ehlers Breaching the brain-blood barrier for drug delivery Neuron 81 2014 1 3
8. H. Amijee C. Bate A. Williams J. Virdee R. Jeggo D. Spanswick D.I. Scopes J.M. Treherne S. Mazzitelli R. Chawner C.E. Eyers A.J. Doig The N-methylated peptide SEN304 powerfully inhibits Aβ(1-42) toxicity by perturbing oligomer formation Biochemistry 51 2012 8338 8352
9. P. Pratim Bose U. Chatterjee C. Nerelius T. Govender T. Norström A. Gogoll A. Sandegren E. Göthelid J. Johansson P.I. Arvidsson Poly-N-methylated amyloid beta-peptide (Abeta) C-terminal fragments reduce Abeta toxicity in vitro and in Drosophila melanogaster J. Med. Chem. 52 2009 8002 8009
10. J. Bieschke M. Herbst T. Wiglenda R.P. Friedrich A. Boeddrich F. Schiele D. Kleckers J.M. Lopez del Amo B.A. Grüning Q. Wang M.R. Schmidt R. Lurz R. Anwyl S. Schnoegl M. Fändrich R.F. Frank B. Reif S. Günther D.M. Walsh E.E. Wanker Small-molecule conversion of toxic oligomers to nontoxic β-sheet-rich amyloid fibrils Nat. Chem. Biol. 8 2011 93 101
11. F. Attanasio M. Convertino A. Magno A. Caflisch A. Corazza H. Haridas G. Esposito S. Cataldo B. Pignataro D. Milardi E. Rizzarelli Carnosine inhibits Aβ(42) aggregation by perturbing the H-bond network in and around the central hydrophobic cluster Chembiochem 14 2013 583 592
12. L. Jiang C. Liu D. Leibly M. Landau M. Zhao M.P. Hughes D.S. Eisenberg Structure-based discovery of fiber-binding compounds that reduce the cytotoxicity of amyloid beta Elife 2 2013 e00857
13. R. Scherzer-Attali R. Pellarin M. Convertino A. Frydman-Marom N. Egoz-Matia S. Peled M. Levy-Sakin D.E. Shalev A. Caflisch E. Gazit D. Segal Complete phenotypic recovery of an Alzheimer's disease model by a quinone-tryptophan hybrid aggregation inhibitor PLoS One 5 2010 e11101
14. M. Convertino A. Vitalis A. Caflisch Disordered binding of small molecules to Aβ(12-28) J. Biol. Chem. 286 2011 41578 41588
15. Y. Chebaro P. Derreumaux Targeting the early steps of Aβ(16-22) protofibril disassembly by n-methylated inhibitors: a numerical study Proteins 75 2009 442 452
16. Y. Chebaro S. Pasquali P. Derreumaux The coarse-grained OPEP force field for non-amyloid and amyloid proteins J. Phys. Chem. B 116 2012 8741 8752
17. F. Sterpone S. Melchionna P. Tuffery S. Pasquali N. Mousseau T. Cragnolini Y. Chebaro J.F. St-Pierre M. Kalimeri A. Barducci Y. Laurin A. Tek M. Baaden P.H. Nguyen P. Derreumaux The OPEP protein model: from single molecules, amyloid formation, crowding and hydrodynamics to DNA/RNA systems Chem. Soc. Rev. 43 2014 4871 4893
18. Y. Chebaro P. Jiang T. Zang Y. Mu P.H. Nguyen N. Mousseau P. Derreumaux Structures of Aβ17-42 trimers in isolation and with five small-molecule drugs using a hierarchical computational procedure J. Phys. Chem. B 116 2012 8412 8422
19. T. Zhang W. Xu Y. Mu P. Derreumaux Atomic and dynamic insights into the beneficial effect of the 1,4-Naphthoquinon-2-yl-l-tryptophan inhibitor on Alzheimer's Aβ1-42 dimer in terms of aggregation and toxicity ACS Chem. Neurosci. 5 2014 148 159
20. E. Mikros D. Benaki E. Humpfer M. Spraul S. Loukas C.I. Stassinopoulou M. Pelecanou High-resolution NMR spectroscopy of the β-amyloid (1-28) fibril typical for Alzheimer's disease Angew. Chem. Int. Ed. Engl. 40 2001 3603 3605
21. B.D. Moore P. Chakrabarty Y. Levites T.L. Kukar A.M. Baine T. Moroni T.B. Ladd P. Das D.W. Dickson T.E. Golde Overlapping profiles of Aβ peptides in the Alzheimer's disease and pathological aging brains Alzheimers Res. Ther. 4 2012 18
22. E. Martineau J.M. de Guzman L. Rodionova X. Kong P.M. Mayer A.M. Aman Investigation of the noncovalent interactions between anti-amyloid agents and amyloid β peptides by ESI-MS J. Am. Soc. Mass. Spectrom. 21 2010 1506 1514
23. B. Tarus P.H. Phuong P. Derreumaux Familial Alzheimer A2V mutation reduces the intrinsic disorder and completely changes the free energy landscape of the Aβ1-28 monomer J. Phys. Chem. B 118 2014 501 510
24. M. Coles W. Bicknell A.A. Watson D.P. Fairlie D.J. Craik Solution structure of amyloid beta-peptide(1-40) in a water-micelle environment. Is the membrane-spanning domain where we think it is? Biochem. (Mosc.) 37 1998 11064 11077
25. H.J.C. Berendsen D. van der Spoel R. van Drunen GROMACS: a message-passing parallel molecular dynamics implementation Comput. Phys. Commun. 91 1995 43 56
26. J.-P. Ryckaert G. Ciccotti H.J.C. Berendsen Numerical integration of the cartesian equations of motion of a system with constraints: molecular dynamics of n-alkanes J. Comput. Phys. 3 1997 327 341
27. T. Darden D. York L. Pedersen Particle mesh Ewald: an N log(N) method for Ewald sums in large systems J. Chem. Phys. 98 1993 10089 10092
28. G. Bussi D. Donadio M. Parrinello Canonical sampling through velocity rescaling J. Chem. Phys. 126 2007 014101
29. P.H. Nguyen M.S. Li P. Derreumaux Effects of all-atom force fields on amyloid oligomerization: replica exchange molecular dynamics simulations of the Aβ(16-22) dimer and trimer Phys. Chem. Chem. Phys. 13 2011 9778 9788
30. K. Lindorff-Larsen S. Piana R.O. Dror D.E. Shaw How fast-folding proteins fold Science 334 2011 517 520
31. P. Derreumaux M. Dauchez G. Vergoten The structures and vibrational frequencies of a series of alkanes using the SPASIBA force field J. Mol. Struct. 295 1993 203 221
32. P. Derreumaux G. Vergoten P. Lagant A vibrational molecular force field of model compounds with biological interest. I. Harmonic dynamics of crystalline urea at 123 K J. Comput. Chem. 11 1990 560 568
33. Marvin Version 5.12.2 2013 ChemAxon http://www.chemaxon.com
34. Suite 2012: Maestro, Version 9.3 2012 Schrödinger, LLC New York, NY
35. ParamChem interface: https://www.paramchem.org.
36. K. Vanommeslaeghe E.P. Raman A.D. MacKerell Jr. Automation of the CHARMM General Force Field (CGenFF) II: assignment of bonded parameters and partial atomic charges J. Chem. Inf. Model 52 2012 3155 3168
37. K. Vanommeslaeghe E. Hatcher C. Acharya S. Kundu S. Zhong J. Shim E. Darian O. Guvench P. Lopes I. Vorobyov A.D. Mackerell Jr. CHARMM general force field: a force field for drug-like molecules compatible with the CHARMM all-atom additive biological force fields J. Comput. Chem. 31 2010 671 690
38. A. Patriksson D. van der Spoel A temperature predictor for parallel tempering simulations Phys. Chem. Chem. Phys. 10 2008 2073 2077
39. D. Frishman P. Argos Knowledge-based protein secondary structure assignment Proteins 23 1995 566 579
40. M.H. Viet P.H. Nguyen S.T. Ngo M.S. Li P. Derreumaux Effect of the Tottori familial disease mutation (D7N) on the monomers and dimers of Aβ40 and Aβ42 ACS Chem. Neurosci. 4 2013 1446 1457
41. R. Scherzer-Attali M. Convertino R. Pellarin E. Gazit D. Segal A. Caflisch Methylations of tryptophan-modified naphthoquinone affect its inhibitory potential toward Aβ aggregation J. Phys. Chem. B 117 2013 1780 1789
42. C. Soto N.C. Inestrosa The alpha-helical to beta-strand transition in the amino-terminal fragment of the amyloid beta-peptide modulates amyloid formation J. Biol. Chem. 270 1995 3063 3067
43. Y. Takahashi T. Yamashita A. Ueno H. Mihara Construction of peptides that undergo structural transition from α-helix to β-sheet and amyloid fibril formation by the introduction of N-terminal hydrophobic amino acids Tetrahedron 56 2000 7011 7018
44. M.D. Kirkitadze M.M. Condron D.B. Teplow Identification and characterization of key kinetic intermediates in amyloid beta-protein fibrillogenesis J. Mol. Biol. 312 2001 1103 1119
45. K. Ono M.M. Condron D.P. Teplow Effects of the English (H6R) and Tottori (D7N) familial Alzheimer disease mutations on amyloid beta-protein assembly and toxicity J. Biol. Chem. 285 2010 23186 23197
46. A. Kapurniotu A. Buck M. Weber A. Schmauder T. Hirsch J. Bernhagen M. Tatarek-Nossol Conformational restriction via cyclization in beta-amyloid peptide Abeta(1-28) leads to an inhibitor of Abeta(1-28) amyloidogenesis and cytotoxicity Chem. Biol. 10 2003 149 159
47. P.H. Nguyen P. Derreumaux Understanding amyloid fibril nucleation and Aβ oligomer/drug interactions from computer simulations Acc. Chem. Res. 47 2014 603 611